Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Integrated Chip System Developed As Complete Laboratory

By LabMedica International staff writers
Posted on 23 Jan 2011
A device, based on chip technology, has been developed that will enable the diagnosis of eight or more different diseases on blood or cell samples. More...


The integrated system based on micro-technology and biotechnology, will enable a number of conditions to be diagnosed automatically in the doctor's own office. The chip looks like a credit card and contains a complete laboratory.

The chip is engraved with a number of very narrow channels that contain chemicals and enzymes in the correct proportions for each individual analysis. When the patient's sample has been drawn into the channels, these reagents are mixed. The card is then put into a machine than can read the biomarkers, such as DNA or enzymes, to produce a diagnosis. The project to develop the chip is being coordinated by SINTEF (Trondheim, Norway), the largest independent research organization in Scandinavia.

Scientists at SINTEF's micro and nanotechnology laboratory have developed a number of techniques for interpreting the results when the biomarkers have been found. For example, they can read them off in a spectrophotometer, an optical instrument in which the ribonucleic acid (RNA) molecules in different markers emit specific fluorescent signals. The project has used cells taken to diagnose cervical cancer as a case study, but in principle, the chip can check out a number of different diseases caused by bacteria or viruses, as well as various types of cancer.

NorChip, (Klokkarstua, Norway), the company that had the original idea, has just started a new two-year EU project that aims to industrialize the diagnostic chip to the mass-production stage while the company will also evaluate market potential and industrial partners. Frank Karlsen, Ph.D., the Chief Scientist at NorChip, said, "The ways in which the chip can be used can be extended to enable patients themselves to take samples at home", and he expects that such special sampling systems will be ready for testing within a few years. The venture is part of the European Commission's (Brussels, Belgium) project ‘Microactive' develops 'in-office' health test system."

Related Links:

SINTEF
NorChip
European Commission



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.